Skip to main content
. 2023 Aug 6;13(13):4430–4448. doi: 10.7150/thno.85369

Figure 4.

Figure 4

Secretory proteins favoring hepatocellular malignant transformation in senescent HSCs. (A) Fold change of 14 secretory proteins in association with HCC development in F30 compared to controls (p < 0.05). (B) Fold change of 13 secretory proteins involved in cell proliferation and tumor invasion in F30 compared to controls (p < 0.05). (C) Fold change of 11 secretory proteins involved in epithelial-mesenchymal transition (EMT) in F30 compared to controls (p < 0.05). (D) Fold change of 4 secretory proteins involved in DNA damage, cell cycle and tumor immune escape in F30 compared to controls (p < 0.05). (E) Fold change of 7 secretory proteins contributing to HCC inhibition in F30 compared to controls (p < 0.05). (F) Protein-protein interaction network (PPI network) of differential secretory proteins. Size and color shade of the cycle represent the number of interacting proteins. Proteins are sorted according to quantity in clockwise.